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Summary
Background: Methadone maintenance treatment in Ireland is provided in addiction clinics, and in primary community 
care settings by Level 1 and 2 specialist trained general practitioners (GPs). The Irish College of General Practitioners 
(ICGP) provides training and regulates the Methadone Treatment Programme (MTP). Aim: The study aimed to assess and 
compare GP perceptions of the scale of local illicit drug use, attitudes toward and obstacles in the provision of methadone 
treatment and preferred adjunct modalities. Methods: In 2006 and 2015, an online survey was undertaken with all Level 1 
and 2 registered GPs in the MTP. Results: The majority of participants were male, aged between 35 and 60 years, treated 
between 1 and 25 patients in urban areas. In 2015, 44.7% with registered methadone patients reported no obstacles to 
taking on more (32% in 2006). In relation to GPs with no current methadone patients, reasons for not taking patients in 
2015 were similar to 2006, and centred on no referrals or demand, and concern for negative affect on private patients. Ma-
jority attitudes toward the MTP remained positive, with one exception relating to greater disagreement in 2015 with the 
statement that supervised daily dispensing prevents patients from working (p < .05). Preferred adjunct services remained 
constant; addiction counselling, in-patient detoxification, employment schemes and consultant psychiatric services. Con-
clusions: The study illustrates a generally positive attitude toward the Irish MTP. Efficient referral mechanisms for sta-
bilised patients to primary care settings, and greater psycho-social, vocational and detoxification supports are warranted.
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1. Introduction
Addiction to opiates is defined as a chronic, re-
lapsing disorder with permanent metabolic deficiency 
[8]. Heroin dependence is the most common form of 
opiate dependence and is a complex condition com-
monly requiring long term treatment modalities typi-
cally incorporating pharmacological, psycho-social 
rehabilitation and relapse prevention interventions 
[3]. Treatment and detoxification using therapeutic 
agents are vital in the care and management of opi-
ate dependent patients, and include oral administra-
tion of full or partial opioid agonists (i.e. methadone, 
buprenorphine, LAAM, codeine or oral morphine) 
[2, 27,]. Methadone maintenance treatment (MMT) 
is the most prescribed treatment worldwide, with the 
exception of France where buprenorphine is preferred 
[4]. Cochrane reviews indicate strong evidence to 
support oral agonist opioid treatment with methadone 
[14, 22,23] with low threshold methadone treatment 
increasing patient reach, uptake and retention, and re-
ducing barriers to access, heroin use, injecting risk 
behaviours, mortality and criminal activity [20, 29]. 
Studies indicate strong retention rates in MMT when 
compared to detoxification [28]. 
Ireland has developed a model of care for de-
livering methadone treatment which acknowledges 
the central role the general practitioner (GP) plays in 
delivering care. MMT has been available since 1992, 
initially confined to the capital, Dublin, and with the 
‘Report of the Expert Group on the Establishment of 
a Protocol for the Prescribing of Methadone’ under-
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taken in 1993. In 1998, the ‘Misuse of Drugs (Su-
pervision of Prescription and Supply of Methadone) 
Regulations’ was introduced which implemented 
specific administrative structures designed to moni-
tor treatment delivery and patient trends. The Irish 
College of General Practitioners (ICGP) has played 
a central role in developing the Methadone Treat-
ment Protocol (MTP) which provided for the delivery 
of methadone treatment in primary care in the Irish 
context. The MTP has presented systematic protocols 
for the prescribing of methadone, management of pa-
tients, a scheme for general practitioner involvement 
in treating patients on methadone, the provision of 
GP training, expansion of methadone patients in the 
community based primary care context, and clinical 
audits [6]. Three types of MMT settings exist in Ire-
land:, in specialised addiction clinics, with Level 1 
trained GPs are restricted to 15 patients, with patient 
stabilisation occurring in specialised addiction clinics 
or with Level 2 trained GPs who are qualified to ini-
tiate treatment, stabilise doses and provide on-going 
maintenance treatment. Inter-referral between Level 
1 and Level 2 GPs is encouraged where this option is 
available. All patients on MMT in Ireland are listed 
on the confidential Central Treatment List (CTL) and 
each patient is listed with one specific prescriber and 
one specific dispensing site only.
Since the introduction of the 1998 MTP, the 
numbers of GPs participating in the MTP scheme 
have increased steadily each year. In 2005, an internal 
review was conducted by the Methadone Prescrib-
ing Implementation Committee. This was followed 
by an external review in 2010 [9], which referred 
to improved prescribing and quality of independent 
practitioner practice in the community. The review 
recommended further consideration of a range of ap-
proaches to maximize treatment provision and inter 
agency referral pathways. In 2015, there were 275 
Level 1 and 70 Level 2 GPs on the CTL listing. 
In the light of the strong evidence base for 
MMT as a treatment option for opiate dependence, 
the ICGP surveyed all Level 1 and 2 registered GPs 
in the Methadone Treatment Programme (MTP) in 
2006 and 2015 in order to assess and compare vari-
ations in GP perceptions of the scale of local illicit 
drug use, attitudes toward and obstacles in the provi-
sion of methadone treatment and preferred additional 
support modalities. 
2. Methods
In 2006 and 2015, an online survey was under-
taken with all GPs in the MTP database. All GPs on 
the database were surveyed regardless of whether 
they had patients currently registered on the CTL. At 
both time points, the survey link was emailed to the 
email address supplied by the MTP with a reminder 
email sent two weeks later. A notice encouraging re-
sponse was also placed on the drug misuse section of 
the ICGP website. Such attitudinal surveys of health 
professionals are exempt from ethical approval in Ire-
land. 
The survey contained a series of descriptive and 
open ended questions. These related to:
• participant and practice profile, specifically 
age, gender, percentage of practice that were 
GMS patients, geographic information, and 
number of GPs in the practice;
• perception of scale of problem, specifically 
whether it was major or minor problem;
• provision of methadone treatment in prac-
tice, specifically whether respondents cur-
rently have any patients on MMT, and 
perceptions around obstacles to providing 
MMT and taking on additional methadone 
patients; 
• attitudes to the methadone treatment pro-
gramme, specifically a series of pre-defined 
statements measuring attitude toward MTP; 
and finally 
• additional services, specifically areas of 
support GPs deem necessary to further en-
hance the services provided to their patients.
Anonymised data yielded descriptive statistics 
(number, percentages) and qualitative open ended 
comment data were manually thematically coded. 
Statistical tests using SPSS included Chi square tests, 
t-tests and p-values were used to assess differences 
in categorical data, with a significance level of 0.05.
3. Results
In 2006, there were 207 responses from 600 
questionnaires sent, giving a response rate of 34.5%. 
In 2015, there were 217 responses from 949 ques-
tionnaires sent, giving a response rate of 22.87%. 
Reminder questionnaires were sent and a reminder 
notice was placed on the drug misuse section of the 
ICGP website for both surveys. Where possible the 
analysis outlined below is based on comparisons be-
tween GPs who had patients on the methadone treat-
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there was a major problem (n=113), while 33.5% 
felt it was a minor problem (n=57). In 2006 (n=141), 
53.2% felt there was a major problem in their practice 
area (n=75) and 46.8% felt it was a minor problem. 
The perception of the scale of the problem in 
reference to location was analysed. It was found that 
the majority of GPS in 2015 who reported that illicit 
drugs were a major problem in their practice area 
were in an urban location (n=86); similar findings 
were reported in 2006 (n=64). The majority of GPs 
from rural areas reported little or minimal problems 
with illicit drug use in their practices. There was no 
observed statistically significant relationship between 
perception of scale of the problem and location; or 
perception of scale of the problem and number of pa-
tients on MTP in the practice. 
3.3. Provision of Methadone Treatment in GP Prac-
tice
Of those GPs who had patients on the metha-
done treatment protocol, in 2015 (n=170) and 2006 
(n=147), the majority were treating between 1 and 25 
patients (Table 2)
GPs who did not currently have methadone pa-
tients were asked to select from a provided list all ob-
stacles to taking on patients. They had the opportunity 
to add detail via open ended comment if they selected 
‘other’. In 2015, of the 46 GPs who indicated that 
they did not currently have patients, just over 51% 
reported that they had ‘never been asked to’ take on 
any patients, while 34% stated that there was ‘no de-
mand’ in their area for methadone treatment. Nearly 
27% of GPs reported that they were concerned that 
treating methadone patients in their practice would 
‘put off private patients’. In 2006, 57 GPs indicated 
that they did not currently have methadone patients. 
Just over 46% of those indicated that they had ‘never 
been asked to’ take on any patients. Approximately 
27% reported that there was ‘no demand’ in their area 
for this form of treatment. (Table 3)
ment protocol from the 2015 survey (n=170) and the 
initial 2006 survey (n=147).
3.1. Participant and Practice Profile
In terms of the profile of GPs, few differences 
were found between the 2006 and 2015 survey groups. 
The majority of GPs remained between 35 and 60 
years of age, and were male. The profile is consistent 
with available statistics on the overall population of 
GPs in Ireland and in the trends evident between 2006 
and 2015, particularly an increase in the proportion 
of females. The majority of practices were described 
as being in urban areas. In 2015, 69.5% of practices 
were located in urban areas, 3% in mixed urban/rural 
and 4.7% in rural (Table 1). 
In Ireland, the General Medical Scheme (GMS) 
operates outside of private health care to provide free 
general practitioner services and free drugs and medi-
cines to persons covered by medical cards. There are 
approximately 1.262 million people eligible to use 
the services under the scheme. In 2006 and 2015 the 
majority of GPs indicated that over 50% of their pa-
tient population were GMS patients. All patients are 
eligible to avail of the MTP free of charge. Single 
handed practices comprised 17.8% of GPs in 2015, a 
decrease from 31.3% in 2006. Both in 2006 and 2015, 
approximately 60% of practices had between two and 
four GPs in practice. 
3.2. Perception of Scale of Problem
In 2015, when asked how big a problem illicit 
drugs were in their practice area, 66.5% of GPs felt 
Table 1: Respondent demographics
Demographics 2006 2015
Age (n=147) (n=168)
<35 14 (9.5%) 19 (11.3%)
35-45 35 (23.8%) 50 (29.8%)
46-60 79 (53.7%) 70 (41.7%)
>60 19 (12.9%) 29 (17.3%)
Sex (n=143) (n=164)
Female 35 (24.5%) 55 (33.5%)
Male 108 (73.5%) 109 (66.5%)
Practice Area (n=147) (n=167)
Urban 111 (75.5%) 116 (69.5%)
Mixed 32 (21.8%) 43 (25.3%)
Rural 4 (2.7%) 8 (4.7%)
Table 2: Number of patients on methadone treatment
2006 2015
n % n %
<25 101 68.7 <25 97 77.6
25-50 38 25.9 25-50 22 17.6
50-75 4 2.7 50-75 3 2.4
>75 4 2.7 >75 3 2.4
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GPs who had patients on the MTP were asked 
to indicate all reasons why they did not take on new 
patients from a provided list. In 2015, 44.7% of GPs 
who had patients on the MTP indicated that there 
were no obstacles to taking on more MTP patients; 
while 32% of GPs in 2006 indicated the same. (Table 
4)
Where ‘other’ was given as a response, GPs 
were asked to specify via open ended comment sec-
tion what other barriers they had encountered to tak-
ing on patients. In 2006 and 2015 common themes 
were ‘work load involved’, ‘partners/practice prin-
cipals not keen’, ‘size/location of premises’, ‘insuf-
ficient community supports’, ‘lack of knowledge/
training’ and ‘personal reasons’. One GP highlighted 
that they felt ‘de-skilled’ in terms of methadone treat-
ment. Specifically in relation to ‘personal reasons’, 
some GPs offered insight on their lack of empathy 
with addicts and highlighted that it was not an enjoy-
able topic area to work in as it ‘can be difficult, cha-
otic and demanding’.
3.4. Attitudes to the Methadone Treatment Pro-
gramme
GPs were asked to rate a number of pre-defined 
statements with regard to the Methadone Treatment 
Programme on a scale from ‘Strongly Agree’ to 
‘Strongly Disagree’. Applying a scoring to responses, 
the mean scores in 2015 were similar to those from 
the 2006 study. The majority of respondents agreed 
that the MTP eliminates chances of double scripting, 
allows for a good relationship with patients, improves 
the health of patients and reduces criminality. 
Opinions regarding the statement that “super-
vised daily dispensing prevents patients from work-
ing” were divided. In 2006 over half of respondents 
(57.8%) agreed that supervised daily dispensing pre-
vents patients from working, while nearly 40% con-
sidered that it did not prevent them from working. 
However in 2015, the proportions were closer and re-
versed with 41.2% agreeing that supervised daily dis-
pensing prevents patients from working, while nearly 
46.5% considered that it did not prevent them from 
working. This shows a shift in GPs’ opinion and may 
be indicative of positive experience with the supervi-
sion element of the programme. (Table 5)
GPs were given the option to comment via open-
ended comment stating “any other comments regard-
ing the MTP” at the end of the statement section. 
Other comments/suggestions given were:
• Need a shorter waiting list.
• Need a system for crisis intervention.
• MTP a little too vigilant for long term pa-
tients/protocol should be more relaxed for 
clean and stable patients.
Table 3: GPs without Methadone Patients - Obstacles to taking on MTP patients
2006 2015 
Obstacles, if any, to taking on patients n % n %
Never been asked to 21 51.2 33 46.5
No demand in the area 14 34.1 19 26.8
Practice too small 2 4.9 2 2.8
Fear of violence 9 22.0 10 14.1
Fear it would put off private patients 11 26.8 10 14.1
Other 19 46.4 35 49.3
Table 4: GPs with Methadone Patients - Obstacles (if any) to taking on additional MTP patients
2006 2015
Obstacles, if any, to taking additional patients n % n %
Have enough already 20 11.8 24 16.3
Have reached protocol maximum 28 16.5 40 27.2
No referrals 46 27.1 22 15.0
Practice staff don’t want anymore 2 1.2 9 6.1
Other patients don’t want anymore 4 2.4 2 1.4
No obstacles 76 44.7 47 32.0
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Figure 1. Areas of support from ICGP re providing care to patients in deprived areas - 2006 v 2015
ment and support services, including community liai-
son officers, literacy support, alcohol support services 
and return to employment services, for patients on 
methadone treatment:
“The biggest drawback at present is the lack 
of access to a community based addiction coun-
sellor without having to go to a treatment centre” 
GP03_2015. 
“(Lack of) rehabilitation assessment and advice 
for all patients and easily accessible psychosocial 
support” GP01_2006.
“The options of a drop in centre and employ-
ment centres are, in my opinion, crucial in managing 
these patients” GP05_2015.
Some GPs also spoke of their lack of familiar-
ity with appropriate services and how best to engage 
with them: “I have difficulties knowing the NGO ser-
vices out there, the various criteria they all use for ac-
• Little help to get patients off methadone.
• Impression is of long duration maintenance.
• Allows time to grow and be decoupled from 
heroin if so desired.
• Additional educational support to facilitate 
patients to become drug free.
Some GPs spoke positively of their experience 
of treating methadone patients “I find methadone 
prescribing one of the more enjoyable aspects of my 
practice. Only at it for less than a year and I still feel 
there's a lot to learn” GP01_2015. While another 
identified their perceived view of their patients expe-
rience to date: “Any patients I have had since I first 
started have done well. I feel I give them good sup-
port and reassurance and a sense of self-worth. They 
are treated with dignity and respect. It is also very 
confidential” GP02_2015. 
GPs also identified a lack of access to assess-
Table 5: Attitudes to the Methadone Treatment Programme 2015 and 2006
Attitudes to the Methadone Treatment Programme 2006 2015 
n Mean SD n Mean SD
Allows good relationship with patients 144 1.65 .583 146 1.65 .537
Provides regular opportunity to monitor progress with 
patients 144 1.58 .549 148 1.48 .501
Essential service for drug users 1.47 1.47 .540 142 1.44 .513
It is an overly rigid protocol 145 2.73 .648 147 2.95 .710
Eliminates chance of double scripting 144 1.78 .650 150 1.77 .689
Improves health of patient 143 1.64 .538 150 1.63 .511
Reduces criminality 143 1.62 .541 150 1.65 .579
Supervised daily dispensing prevents patients from 
working 141 2.30 .684 148 2.47 .760
It is difficult to get off methadone 142 1.93 .637 150 1.86 .695
Keeps patients addicted to substance 141 2.27 .745 148 2.32 .767
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without problems. A minority of GPs reported con-
cerns relating to potential negative effect on private 
patients. Studies have reported on GP reluctance to 
offer MMT in primary care as grounded in perceived 
lack of skills and expertise, workload, concerns 
around displacement of stigma from clinics into pri-
vate/general practice and personal and staff safety [1, 
6, 10, 12, 15, 17, 19, 21, 24, 31]. Of note, were the 
encouraging results around lack of obstacles to taking 
on more MTP patients, and that some GPs reported no 
current methadone patients due to lack of demand or 
referral. This indicates that there is significant scope 
for increasing the numbers of MTP patients in pri-
mary care in Ireland if GPs are approached by the rel-
evant agencies. There is a need for continued support 
of existing Level 1 and 2 GPs, training of additional 
Level 1 GPs, and encouragement of further training 
to Level 2. Studies have indicated that newly qualified 
doctors report greater acceptance of problematic drug 
users, and self-awareness of their competency to treat 
dependencies [7,13]. 
The World Health Organisation guidelines ad-
vise that long term and multi component treatment 
modalities for opiate dependence incorporate ele-
ments of pharmacological, psycho-social rehabilita-
tion and relapse prevention interventions within spe-
cialized stabilization and primary care settings [35]. 
Earlier qualitative research with Irish GPs involved 
in the MTP in 2013 underscored the need for a bio 
psycho social approach to treating opiate depend-
ence within expanded interagency community based 
medical and psychosocial treatment detoxification 
provision. This study also illustrated how MTP GPs 
in Ireland currently navigate a multiplicity of roles, 
relating to patient advocacy, medical expertise and 
detoxification gatekeeping [31]. GP views in this 
national survey were similar and remained constant 
over time, thus highlighting the need for policy dis-
course and MTP expansion to incorporate such addi-
tional support modalities, and to additionally include 
employment support. Irish research in 2012 and 2014 
has also emphasised the need to incorporate vocation-
al and employment skills training into current levels 
and format of MMT provision [30, 32]. 
Limitations
Clearly the response rate is a limiting factor 
in this study, however, it is typical of response rates 
from GPs. Furthermore, the profile of those who did 
reply is consistent with the national GP population 
and the overall MTP GP population and are therefore 
cess to services, and generally how to link with them” 
GP 06_2015.
3.5. Additional Services
GPs were asked to rank from a provided list their 
top three areas of support they deem necessary to fur-
ther enhance the services provided to their patients. 
The results of the 2015 survey and the 2006 survey 
reported similar findings. In both years, GPs selected 
addiction counselling as their primary choice (46.5% 
2015; 51.7% 2006), followed by in-patient rehabilita-
tion detoxification beds (24.1% 2015; 26.5% 2006), 
Of interest, the percentage of GPs who selected em-
ployment schemes and drop-in/social centres as their 
first choice in 2006 notably increased from 8.9% and 
0.7% respectively to 21.2% and 11.76% in 2015.
4. Discussion
Given the unique nature of methadone treatment 
provision in specialist clinics and in community pri-
mary care settings, this Irish study yielded encourag-
ing findings with regard to GP views on participation 
in the MTP, perceptions of the scale of local illicit 
drug use, obstacles and attitudes toward the provi-
sion of methadone treatment and preferred additional 
support modalities. Care of drug users in the commu-
nity by primary care is extensively discussed in the 
literature, and is particularly cognisant of challenges 
presented by injecting drug users [1, 16, 17, 25, 33]. 
High methadone patient turnover, consultation time 
pressures and emergency appointments remain char-
acteristic of the treatment cohort [18, 26]. Drug users 
themselves also report a preference for the treatment 
of their dependency within general practice [5]. Posi-
tive outcomes relate to methadone patient satisfac-
tion, reduced criminal activity and drug use, and up-
take in adjunct medical and social services [11, 15, 
34]. Of note, was that the majority of GPs’ attitudes 
toward the MTP remained positive over time, in that 
it is an essential service to drug users, improves pa-
tient health, allows a good relationship with patients, 
provides regular opportunity to monitor progress with 
patients, and reduces criminality, with one exception 
relating to increased disagreement that supervised 
daily dispensing prevents methadone patients from 
working. An earlier qualitative Irish study observed 
positive GP observations on MMT around harm re-
duction outcomes, and how MMT represents an im-
portant turning point for patients [31]. 
We recognise that the provision of MMT is not 
- 11 -
I. Delargy et al.: General Practitioner perspectives on and attitudes toward the Methadone Treatment Programme in Ireland
generalisable. Although this MTP model is unique to 
the Irish setting, and the findings presented are based 
on it, the model could be closely replicated across pri-
mary care settings in other countries and hence the 
findings could inform the establishment of such pro-
grammes.
5. Conclusions 
Given the specialist and community primary 
care approach to providing MMT in Ireland, to a large 
degree GPs present a key and essential resource in the 
treatment of opiate and other drug misuse, and have 
responded well to the challenge of managing drug us-
ers. The study illustrates a generally positive attitude 
toward the Irish MTP, with a need for greater effi-
ciency of referral mechanisms for stabilised patients 
to primary care settings, and greater incorporation of 
psycho-social, vocational and detoxification supports 
warranted. 
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